Position in NSRX
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$86,351
New position
Shares Held
38,897
first reported quarter
Ownership
0.332%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026HRT FINANCIAL LP holds $691,078,789 across 12 Drug Manufacturers - General names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
1,031,961 | $262,087,135 | |
| 2 | ABBV |
AbbVie Inc.
|
702,907 | $176,879,517 | |
| 3 | MRK |
Merck & Co., Inc.
|
798,048 | $102,549,168 | |
| 4 | LLY |
ELI LILLY & Co
|
38,616 | $46,317,192 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
741,187 | $42,707,194 | |
| 6 | GSK |
GSK plc
|
603,902 | $31,656,542 | |
| 7 | NVS |
Novartis AG
|
89,587 | $14,040,074 | |
| 8 | NVO |
Novo Nordisk A S
|
148,940 | $7,140,183 |
All Filings in NSRX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $86,351 | 38,897 | Shares | Defined | 2026-05-14 | |
| No filing history on record for this holder in this stock. | ||||||